Skip to content
GLP-1 Decoder

Ozempic Headache: How Common, How Long It Lasts, What Helps

Headache does not appear on the Ozempic label as a side effect. What people mean by it: pain in the head.

In the label
Not listed
Most common in the label
Nausea 20.3%

A quick look at Ozempic

How long it stays in your body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and about 3% remains after five half-lives (35 d).

Weight loss in the main trial
Ozempic (SUSTAIN 1)4.7 kgPlacebo1.2 kg

For people with type 2 diabetes, SUSTAIN 1 covered 30 weeks: 4.7 kg lost versus 1.2 kg with placebo.

Prices across periods
202520262027$1,027.51$0List priceSelf-pay

Each month’s figures in US dollars cover both the list price and self-pay offers. They come from the maker’s price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

What the Ozempic label lists instead

Headache does not appear on the Ozempic label. It lists these five side effects more often than any others.

Table 1. Adverse Reactions identified in Placebo-Controlled Trials Reported in ≥5% of OZEMPIC-Treated Patients with Type 2 Diabetes Mellitus
Side effectPlaceboOzempic 0.5 mgOzempic 1 mgMore than placebo, 1 mg
Nausea6.1%15.8%20.3%+14.2 points
Vomiting2.3%5%9.2%+6.9 points
Diarrhea1.9%8.5%8.8%+6.9 points
Abdominal pain4.6%7.3%5.7%+1.1 points
Constipation1.5%5%3.1%+1.6 points

Source: Ozempic label (DailyMed).

Headache: Ozempic and other GLP-1s compared

Each label describes its own trials, which involved different groups of people. Treat it as a rough guide.

The table lists the pill forms as well: Foundayo.

Headache across GLP-1 labels
MedicineHighest rate in the labelDose groupPlaceboPeople in the trials
Wegovy14%2.4 mg10%Adults with obesity or overweight (weight management)
Saxenda13.6%all doses12.6%Adults with obesity or overweight (weight management)
Victoza11%1.2 mg7%Adults with type 2 diabetes
Foundayo9%9 mg7%Adults with obesity or overweight (weight management)
Byetta9%all doses6%Adults with type 2 diabetes
OzempicNot listed–––
RybelsusNot listed–––
MounjaroNot listed–––
ZepboundNot listed–––
TrulicityNot listed–––

Sources: Wegovy label (DailyMed), Foundayo label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).

Source: FDA label (DailyMed).